Â鶹ԭ´´

1 Report Overview
1.1 Study Scope
1.2 Â鶹ԭ´´ Analysis by Type
1.2.1 Global Genome Sequencing Service Â鶹ԭ´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Whole-Genome Sequencing
1.2.3 Whole exome Sequencing
1.3 Â鶹ԭ´´ by Application
1.3.1 Global Genome Sequencing Service Â鶹ԭ´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Humanity
1.3.3 Plant
1.3.4 Animal
1.3.5 Microorganism
1.3.6 Virus
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Sequencing Service Â鶹ԭ´´ Perspective (2018-2029)
2.2 Genome Sequencing Service Growth Trends by Region
2.2.1 Global Genome Sequencing Service Â鶹ԭ´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genome Sequencing Service Historic Â鶹ԭ´´ Size by Region (2018-2023)
2.2.3 Genome Sequencing Service Forecasted Â鶹ԭ´´ Size by Region (2024-2029)
2.3 Genome Sequencing Service Â鶹ԭ´´ Dynamics
2.3.1 Genome Sequencing Service Industry Trends
2.3.2 Genome Sequencing Service Â鶹ԭ´´ Drivers
2.3.3 Genome Sequencing Service Â鶹ԭ´´ Challenges
2.3.4 Genome Sequencing Service Â鶹ԭ´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Sequencing Service Players by Revenue
3.1.1 Global Top Genome Sequencing Service Players by Revenue (2018-2023)
3.1.2 Global Genome Sequencing Service Revenue Â鶹ԭ´´ Share by Players (2018-2023)
3.2 Global Genome Sequencing Service Â鶹ԭ´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Sequencing Service Revenue
3.4 Global Genome Sequencing Service Â鶹ԭ´´ Concentration Ratio
3.4.1 Global Genome Sequencing Service Â鶹ԭ´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Sequencing Service Revenue in 2022
3.5 Genome Sequencing Service Key Players Head office and Area Served
3.6 Key Players Genome Sequencing Service Product Solution and Service
3.7 Date of Enter into Genome Sequencing Service Â鶹ԭ´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Sequencing Service Breakdown Data by Type
4.1 Global Genome Sequencing Service Historic Â鶹ԭ´´ Size by Type (2018-2023)
4.2 Global Genome Sequencing Service Forecasted Â鶹ԭ´´ Size by Type (2024-2029)
5 Genome Sequencing Service Breakdown Data by Application
5.1 Global Genome Sequencing Service Historic Â鶹ԭ´´ Size by Application (2018-2023)
5.2 Global Genome Sequencing Service Forecasted Â鶹ԭ´´ Size by Application (2024-2029)
6 North America
6.1 North America Genome Sequencing Service Â鶹ԭ´´ Size (2018-2029)
6.2 North America Genome Sequencing Service Â鶹ԭ´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genome Sequencing Service Â鶹ԭ´´ Size by Country (2018-2023)
6.4 North America Genome Sequencing Service Â鶹ԭ´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Sequencing Service Â鶹ԭ´´ Size (2018-2029)
7.2 Europe Genome Sequencing Service Â鶹ԭ´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genome Sequencing Service Â鶹ԭ´´ Size by Country (2018-2023)
7.4 Europe Genome Sequencing Service Â鶹ԭ´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Sequencing Service Â鶹ԭ´´ Size (2018-2029)
8.2 Asia-Pacific Genome Sequencing Service Â鶹ԭ´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genome Sequencing Service Â鶹ԭ´´ Size by Region (2018-2023)
8.4 Asia-Pacific Genome Sequencing Service Â鶹ԭ´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Sequencing Service Â鶹ԭ´´ Size (2018-2029)
9.2 Latin America Genome Sequencing Service Â鶹ԭ´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genome Sequencing Service Â鶹ԭ´´ Size by Country (2018-2023)
9.4 Latin America Genome Sequencing Service Â鶹ԭ´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Sequencing Service Â鶹ԭ´´ Size (2018-2029)
10.2 Middle East & Africa Genome Sequencing Service Â鶹ԭ´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genome Sequencing Service Â鶹ԭ´´ Size by Country (2018-2023)
10.4 Middle East & Africa Genome Sequencing Service Â鶹ԭ´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Genome Sequencing Service Introduction
11.1.4 Illumina Revenue in Genome Sequencing Service Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Genome Sequencing Service Introduction
11.2.4 Thermo Fisher Scientific Revenue in Genome Sequencing Service Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 BGI Genomics
11.3.1 BGI Genomics Company Detail
11.3.2 BGI Genomics Business Overview
11.3.3 BGI Genomics Genome Sequencing Service Introduction
11.3.4 BGI Genomics Revenue in Genome Sequencing Service Business (2018-2023)
11.3.5 BGI Genomics Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Genome Sequencing Service Introduction
11.4.4 Agilent Technologies Revenue in Genome Sequencing Service Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 10X Genomics
11.5.1 10X Genomics Company Detail
11.5.2 10X Genomics Business Overview
11.5.3 10X Genomics Genome Sequencing Service Introduction
11.5.4 10X Genomics Revenue in Genome Sequencing Service Business (2018-2023)
11.5.5 10X Genomics Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genome Sequencing Service Introduction
11.6.4 QIAGEN Revenue in Genome Sequencing Service Business (2018-2023)
11.6.5 QIAGEN Recent Development
11.7 GENEWIZ
11.7.1 GENEWIZ Company Detail
11.7.2 GENEWIZ Business Overview
11.7.3 GENEWIZ Genome Sequencing Service Introduction
11.7.4 GENEWIZ Revenue in Genome Sequencing Service Business (2018-2023)
11.7.5 GENEWIZ Recent Development
11.8 Macrogen
11.8.1 Macrogen Company Detail
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Genome Sequencing Service Introduction
11.8.4 Macrogen Revenue in Genome Sequencing Service Business (2018-2023)
11.8.5 Macrogen Recent Development
11.9 GE Healthcare Life Sciences
11.9.1 GE Healthcare Life Sciences Company Detail
11.9.2 GE Healthcare Life Sciences Business Overview
11.9.3 GE Healthcare Life Sciences Genome Sequencing Service Introduction
11.9.4 GE Healthcare Life Sciences Revenue in Genome Sequencing Service Business (2018-2023)
11.9.5 GE Healthcare Life Sciences Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Genome Sequencing Service Introduction
11.10.4 Johnson & Johnson Revenue in Genome Sequencing Service Business (2018-2023)
11.10.5 Johnson & Johnson Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Detail
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Genome Sequencing Service Introduction
11.11.4 Abbott Laboratories Revenue in Genome Sequencing Service Business (2018-2023)
11.11.5 Abbott Laboratories Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Genome Sequencing Service Introduction
11.12.4 Bayer Revenue in Genome Sequencing Service Business (2018-2023)
11.12.5 Bayer Recent Development
11.13 Microchip Biotechnologies
11.13.1 Microchip Biotechnologies Company Detail
11.13.2 Microchip Biotechnologies Business Overview
11.13.3 Microchip Biotechnologies Genome Sequencing Service Introduction
11.13.4 Microchip Biotechnologies Revenue in Genome Sequencing Service Business (2018-2023)
11.13.5 Microchip Biotechnologies Recent Development
11.14 Myriad Genetics
11.14.1 Myriad Genetics Company Detail
11.14.2 Myriad Genetics Business Overview
11.14.3 Myriad Genetics Genome Sequencing Service Introduction
11.14.4 Myriad Genetics Revenue in Genome Sequencing Service Business (2018-2023)
11.14.5 Myriad Genetics Recent Development
11.15 Commonwealth Biotechnologies
11.15.1 Commonwealth Biotechnologies Company Detail
11.15.2 Commonwealth Biotechnologies Business Overview
11.15.3 Commonwealth Biotechnologies Genome Sequencing Service Introduction
11.15.4 Commonwealth Biotechnologies Revenue in Genome Sequencing Service Business (2018-2023)
11.15.5 Commonwealth Biotechnologies Recent Development
11.16 ZS Genetics
11.16.1 ZS Genetics Company Detail
11.16.2 ZS Genetics Business Overview
11.16.3 ZS Genetics Genome Sequencing Service Introduction
11.16.4 ZS Genetics Revenue in Genome Sequencing Service Business (2018-2023)
11.16.5 ZS Genetics Recent Development
11.17 Pacific Biosciences
11.17.1 Pacific Biosciences Company Detail
11.17.2 Pacific Biosciences Business Overview
11.17.3 Pacific Biosciences Genome Sequencing Service Introduction
11.17.4 Pacific Biosciences Revenue in Genome Sequencing Service Business (2018-2023)
11.17.5 Pacific Biosciences Recent Development
11.18 Novogene
11.18.1 Novogene Company Detail
11.18.2 Novogene Business Overview
11.18.3 Novogene Genome Sequencing Service Introduction
11.18.4 Novogene Revenue in Genome Sequencing Service Business (2018-2023)
11.18.5 Novogene Recent Development
11.19 Eurofins Genomics
11.19.1 Eurofins Genomics Company Detail
11.19.2 Eurofins Genomics Business Overview
11.19.3 Eurofins Genomics Genome Sequencing Service Introduction
11.19.4 Eurofins Genomics Revenue in Genome Sequencing Service Business (2018-2023)
11.19.5 Eurofins Genomics Recent Development
11.20 Psomagen
11.20.1 Psomagen Company Detail
11.20.2 Psomagen Business Overview
11.20.3 Psomagen Genome Sequencing Service Introduction
11.20.4 Psomagen Revenue in Genome Sequencing Service Business (2018-2023)
11.20.5 Psomagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details